Status:
COMPLETED
SGLT Inhibitors Versus DDP4 Inhibitors and Prostate in Patient With Diabetes
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
Diabetes Mellitus
Prostatic Hyperplasia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study aims to compare the effect of two different classes of anti- diabetes medications on prostate volume and symptoms in elderly patients with diabetes mellitus
Detailed Description
The study aims to compare the effect of two different classes of anti- diabetes medications on prostate volume and symptoms in elderly patients with diabetes mellitus The study compares sodium glucose...
Eligibility Criteria
Inclusion
- Patients with diabetes and benign prostatic hyperplasia should be on monotherapy with either SGLT inhibitor or DDP4 inhibitors
Exclusion
- unable to consent to the blood sampling or ultrasound Any other diabetes control measure other than SGLT inhibitors or DDP 4 inhibitors
Key Trial Info
Start Date :
March 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 13 2022
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT06148259
Start Date
March 12 2021
End Date
September 13 2022
Last Update
November 28 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo university hospitals
Cairo, Egypt
2
Kasr Alainy University Hospitals
Cairo, Egypt